KR890001989A - 펜타디엔아미드 - Google Patents
펜타디엔아미드 Download PDFInfo
- Publication number
- KR890001989A KR890001989A KR1019880008471A KR880008471A KR890001989A KR 890001989 A KR890001989 A KR 890001989A KR 1019880008471 A KR1019880008471 A KR 1019880008471A KR 880008471 A KR880008471 A KR 880008471A KR 890001989 A KR890001989 A KR 890001989A
- Authority
- KR
- South Korea
- Prior art keywords
- lower alkyl
- compound
- formula
- hydrogen
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (27)
- 일반식(Ⅰ)의 화합물, 이의 에난티오머 및 라세미체 혼합물(R6및 R7이 다를 경우), 기하이성체(R1및 R2가 다를 경우) 및 이들의 약학적으로 허용되는 산부가염.상기식에서, Y는 o 또는 s이고*A는 피라페닐렌 또는*-(CH2)n-(X)m-(CH2)r-이고 X는 o, s 또는 -CH=CH-이고, n 및 r은 독립적으로 0 내지 3의 정수이고 s는 0 또는 1이고, m은 0 또는 1이며, 단 m이 1일 경우 n+s는 2이상이고, R1및 R2는 독립적으로, 수소, 저급알킬, 저급사이클로알킬, 저급알케닐, Het 또는 아릴이고, R3, R4및 R5및 R8은 독립적으로, 수소, 저급알킬 또는 아릴이고, R5, 및 R7은 독립적으로, 수소 또는 저급알킬이고, R6는 수소 저급알킬, 저급사이클로알킬, Het-저급알킬 또는 아릴이고 Het는 질소, 산소 및 황중에서 선택된 1 또는 2개의 헤테로원자를 함유하는 모노사이클릭 5- 또는 6-원 헤테로방향족 또는 비사이클릭 헤테로방향족 라디칼(이 라디칼은 저급알킬, 할로겐 또는 아릴로 치환 될 수 있다)이고 *는 결합 위치를 나타낸다.
- 제 1항에 있어서, 하기 일반식(Ⅰb)의 화합물.(E)-또는 트랜스-이성체
- 제 1항에 있어서, 하기 일반식(Ⅰc)의 화합물.(Z)-또는 시스-이성체
- 제 1항에 있어서, 하기 일반식(Ⅰd)의 화합물.(R)-배열을 갖는[R-(Z)]-이성체
- 제 1항에 있어서, 하기 일반식(Ⅰe)의 화합물.(R)- 배열을 갖는 [R-(E)] -이성체
- 제 1항에 있어서, 하기 일반식(Ⅰf)의 화합물.(S)- 배열을 갖는 [S-(Z)] -이성체
- 제 1항에 있어서, 일반식(Ⅰg)의 화합물.(S)- 배열을 갖는 [S-(E)] -이성체
- 제1항 내지 제7항 중 어느 한 항에 있어서, R1및 R2가 독립적으로 저급알킬 또는 아릴이고, R3, R4및 R8이 독립적으로 수소 또는 저급알킬이며, R5및 R7이 수소이고, R6가 수소, 저급알킬 또는 저급사이클로알킬이며,*A가*-(CH2)n-(X)m-(CH2)r-이고, n+r이 2 내지 6의 정수이며, m이 0이고, Het가 질소, 산소 및 황중에서 선택된 1 또는 2개의 헤테로원자를 함유하는 모노사이클릭 5- 또는 6-원 헤테로방향족 환이며, y가 산소 또는 황이고 s가 1인 화합물.
- 제8항에 있어서, R1이 저급알킬 또는 아릴이고, R2가 아릴이며, R3, R4, 및 R8이 독립적으로 수소 또는 저급알킬이고,*A가*-(CH2)n-(X)m-(CH2)r-이며, n+r이 3이고 m이 0이며, Het가 저급 알킬로 임의 치환된 피라디닐 또는 피리미디닐이고, R5및 R7이, 수소이며 R6가 수소, 저급알킬 또는 사이클로프로필이고, y가 산소이며, s가 1인 화합물.
- 제9항에 있어서, R1이 부틸, 펜틸, 또는 헥실이거나, 저급알콕시 및 할로겐 중에서 선택된 3개 이하의 치환체를 갖는 페닐이고 R2가 할로겐 및 저급알콕시 중에서 선택된 3개 이하의 치환체를 갖는 페닐이며, R3, R4, R5, R7, 및 R8이 수소이고, Het가 3-피리디닐 또는 2-메틸-3-피리디닐인 화합물.
- [R-(E,E)]-5-(4-메톡시페닐)-N-[1-메틸-4-(3-피리디닐)부틸]-2,4-데카디엔아미드.
- [R-(E,E)]-5-(4-메톡시페닐)-N-[1-메틸-4-(3-피리디닐)부틸]-2,4-노나디엔아미드.
- (E)-5,5-비스(3-플루오로페닐)-N-[4-(3-피리디닐)부틸]-2,4-펜타디엔아미드.
- [R-(E)]-N-[1-에틸-4-(3-피리디닐)부틸]-5,5-비스(4-메톡시페닐)-2,4-펜타디엔아미드.
- [R,S-(E,E)]-5-(4-메톡시페닐)-N-[1-메틸-4-(2-메틸-3-피리디닐)부틸]-2,4-데카디엔아미드.
- (E)-5,5-비스(3-메톡시페닐)-N-[4-(3-피리디닐)부틸]-2,4-펜타디엔아미드.
- 제1항 내지 제16항 중 어느 한 항에 있어서, 치료학적 활성물질로 사용하기 위한 화합물.
- 제 1항 내지 제16항 중 어느 한 항에 있어서, 혈소판 활성화인자(PAF)길항제로서 사용하기 위한 화합물.
- a) 일반식(Ⅱ)의 카복실산의 반응성 유도체를 일반식(Ⅴ)의 화합물과 반응시키거나, b) 일반식(Ⅱ)의 카복실산을 트리(저급알킬)- 또는 트리아릴포스핀 존재하에 일반식(Ⅶ)의 아지드와 반응시키거나, c) Y가 O인 일반식(Ⅰ)의 화합물을 오황화인과 반응시켜 Y가 S인 상응하는 일반식(Ⅰ)의 화합물을 수득하고, d) 필요한 경우, 수득된 일반식(Ⅰ)의 화합물을 약제학적으로 허용되는 산부가염으로 전환시킴을 특징으로하여, 제 1항 내지 제16항 중 어느 한 항에 따른 일반식(Ⅰ)의 화합물 및 이의 약제학적으로 무독한 산부가염을 제조하는 방법.상기식에서, R1, R2, R3, R4, R5, R6, R7, R8,*A, Het 및 S는 제 1항에서 정의한 바와 같다.
- 제 1 내지 제16항 중 어느 한 항에 따른 화합물 및 치료학적 불활성 담체를 함유하는 약재학적 조성물.
- 제 1항 내지 제16항 중 어느 한 항에 따른 화합물 및 치료학적 불활성 담체를 함유하는, 혈소판 활성화인자 길항활성을 나타내는 약제학적 조성물.
- 질병을 예방 또는 억제하기 위한, 제 1항 내지 제16항 중 어느 한 항에 따른 화합물의 용도.
- 과다한 혈소판 활성화인자로 인한 질환이나 심장혈관계질환, 폐동맥계질환, 면역학적 장해, 염증, 피부질환, 쇼크 또는 이식거부반응을 예방 또는 억제하기 위한 제 1항 내지 제16항 중 어느 한 항에 따른 화합물의 용도.
- 혈소판 활성화인자 길항활성을 나타내는 약제학적 조성물을 제조하기 위한, 제 1 내지 제16항 중 어느 한 항에 따른 화합물의 용도.
- 제 1항 내지 제16항 중 어느 하나에 있어서, 재19항에 따른 방법 또는 이와 화학적으로 명백히 균등한 방법에 따라 제조된 화합물.
- 상술한 바와 같은 발명.
- 제 1항 내지 제16항 중 어느 한 항에 따른 화합물 유효량을 이를 필요로 하는 환자에게 투여함을 특징으로 하여, 과다한 혈소판 활성화인자로 인한 질환이나 심장혈관계질환, 폐동맥계질환, 면역학적 장해, 염증, 피부질환, 쇼크 또는 이식거부반응을 치료하는 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US072,389 | 1987-07-10 | ||
US07/072,389 US4788206A (en) | 1987-07-10 | 1987-07-10 | Pentadieneamides |
Publications (1)
Publication Number | Publication Date |
---|---|
KR890001989A true KR890001989A (ko) | 1989-04-07 |
Family
ID=22107243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019880008471A KR890001989A (ko) | 1987-07-10 | 1988-07-08 | 펜타디엔아미드 |
Country Status (21)
Country | Link |
---|---|
US (1) | US4788206A (ko) |
EP (1) | EP0299379B1 (ko) |
JP (1) | JPS6431766A (ko) |
KR (1) | KR890001989A (ko) |
AT (1) | ATE88466T1 (ko) |
AU (1) | AU626526B2 (ko) |
CZ (1) | CZ394991A3 (ko) |
DE (1) | DE3880387D1 (ko) |
DK (1) | DK378188A (ko) |
ES (1) | ES2054740T3 (ko) |
FI (1) | FI883290A (ko) |
HU (1) | HU205902B (ko) |
IL (1) | IL87017A0 (ko) |
MC (1) | MC1954A1 (ko) |
MX (1) | MX9203599A (ko) |
NO (1) | NO883084L (ko) |
NZ (1) | NZ225327A (ko) |
PH (1) | PH24605A (ko) |
PT (1) | PT87953B (ko) |
YU (1) | YU46716B (ko) |
ZA (1) | ZA884857B (ko) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ225307A (en) * | 1987-07-10 | 1991-06-25 | Hoffmann La Roche | Heterocyclic containing alkene derivatives and pharmaceutical compositions |
US5192766A (en) * | 1989-04-28 | 1993-03-09 | Sankyo Company, Limited | N-acryloylpiperazine derivatives, their preparation and their use as PAF antagonists |
US5369106A (en) * | 1989-04-28 | 1994-11-29 | Sankyo Company, Limited | N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists |
DK0900200T5 (da) * | 1996-04-23 | 2010-01-11 | Targacept Inc | Farmaceutiske sammensætninger til forebyggelse og behandling af sygdom i centralnervesystemet |
KR100568997B1 (ko) * | 1996-04-23 | 2006-12-15 | 타가셉트 인코포레이티드 | 중추신경계질환의예방및치료를위한약제학적조성물 |
AU2652397A (en) * | 1996-05-13 | 1997-12-05 | Nippon Shinyaku Co. Ltd. | Substituted ethylene compounds and drugs |
ATE270277T1 (de) * | 1997-12-11 | 2004-07-15 | Janssen Pharmaceutica Nv | Anilide als vitamin-a-säure-mimetika |
US6232316B1 (en) | 1998-06-16 | 2001-05-15 | Targacept, Inc. | Methods for treatment of CNS disorders |
DE19828463A1 (de) * | 1998-06-26 | 1999-12-30 | Basf Ag | 4,4-Diarylbutadiene als wasserlösliche photostabile UV-Filter für kosmetische und pharmazeutische Zubereitungen |
US6455554B1 (en) | 1999-06-07 | 2002-09-24 | Targacept, Inc. | Oxopyridinyl pharmaceutical compositions and methods for use |
AU5326100A (en) * | 1999-06-07 | 2000-12-28 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
DE60325834D1 (de) * | 2002-02-20 | 2009-03-05 | Abbott Lab | Kondensierte azabicyclischeverbindungen als inhibitoren des vanilloid-rezeptors 1 (vr1) |
WO2004078144A2 (en) * | 2003-03-05 | 2004-09-16 | Celgene Corporation | Diphenylethylene compounds and uses thereof |
US8013006B2 (en) * | 2004-07-14 | 2011-09-06 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
US7781478B2 (en) * | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
US7772271B2 (en) * | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
US7868037B2 (en) * | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
JP2008507518A (ja) * | 2004-07-22 | 2008-03-13 | ピーティーシー セラピューティクス,インコーポレーテッド | C型肝炎を治療するためのチエノピリジン |
EP2050734A1 (en) | 2006-07-13 | 2009-04-22 | Kyowa Hakko Kirin Co., Ltd. | Pentadienamide derivative |
US7767705B2 (en) | 2006-08-25 | 2010-08-03 | Abbott Laboratories | Compounds that inhibit TRPV1 and uses thereof |
MX2011001887A (es) * | 2008-08-22 | 2011-04-04 | Baxter Int | Derivados de bencil carbonato polimericos. |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3072649A (en) * | 1963-01-08 | S-tmalkoxycinnamamide derivatives | ||
US4568687A (en) * | 1983-02-28 | 1986-02-04 | American Cyanamid Company | N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical compositions |
US4568685A (en) * | 1984-02-29 | 1986-02-04 | American Cyanamid Company | N-[(1H-1,2,4-Triazol-1-yl)alkyl]-arylamides |
US4542145A (en) * | 1984-02-29 | 1985-09-17 | American Cyanamid Company | Substituted N-[(1H-1,2,4-triazol-1-yl)-alkyl]heteroarylcarboxamides |
US4673684A (en) * | 1984-04-04 | 1987-06-16 | Terumo Corporation | Amide derivatives and 5-lipoxygenase inhibitors containing the same as an active ingredient |
JPS6144870A (ja) * | 1984-08-10 | 1986-03-04 | Terumo Corp | 不飽和脂肪酸アミド誘導体およびこれを含有する血小板凝集抑制剤 |
JPS6144869A (ja) * | 1984-08-10 | 1986-03-04 | Terumo Corp | イミダゾ−ル誘導体およびこれを含有する血小板凝集抑制剤 |
JPS6212757A (ja) * | 1985-07-10 | 1987-01-21 | Yoshitomi Pharmaceut Ind Ltd | 桂皮酸アミド誘導体 |
US4778796A (en) * | 1985-07-19 | 1988-10-18 | Dainippon Pharmaceutical Co., Ltd. | ω-(3-pyridyl)alkenamide derivatives and anti-allergenic pharmaceutical compositions containing same |
JPH06144869A (ja) * | 1992-11-10 | 1994-05-24 | Matsunami Glass Kogyo Kk | バイオ担体用多孔質ガラス |
-
1987
- 1987-07-10 US US07/072,389 patent/US4788206A/en not_active Expired - Fee Related
-
1988
- 1988-07-06 IL IL87017A patent/IL87017A0/xx unknown
- 1988-07-06 ZA ZA884857A patent/ZA884857B/xx unknown
- 1988-07-07 DK DK378188A patent/DK378188A/da not_active Application Discontinuation
- 1988-07-07 NZ NZ225327A patent/NZ225327A/xx unknown
- 1988-07-08 EP EP88110934A patent/EP0299379B1/de not_active Expired - Lifetime
- 1988-07-08 PH PH37197A patent/PH24605A/en unknown
- 1988-07-08 AU AU18851/88A patent/AU626526B2/en not_active Ceased
- 1988-07-08 NO NO88883084A patent/NO883084L/no unknown
- 1988-07-08 FI FI883290A patent/FI883290A/fi not_active Application Discontinuation
- 1988-07-08 YU YU132488A patent/YU46716B/sh unknown
- 1988-07-08 HU HU883584A patent/HU205902B/hu not_active IP Right Cessation
- 1988-07-08 KR KR1019880008471A patent/KR890001989A/ko not_active Application Discontinuation
- 1988-07-08 PT PT87953A patent/PT87953B/pt not_active IP Right Cessation
- 1988-07-08 MC MC881989A patent/MC1954A1/xx unknown
- 1988-07-08 AT AT88110934T patent/ATE88466T1/de not_active IP Right Cessation
- 1988-07-08 DE DE8888110934T patent/DE3880387D1/de not_active Expired - Fee Related
- 1988-07-08 ES ES88110934T patent/ES2054740T3/es not_active Expired - Lifetime
- 1988-07-10 JP JP63171720A patent/JPS6431766A/ja active Pending
-
1991
- 1991-12-20 CZ CS913949A patent/CZ394991A3/cs unknown
-
1992
- 1992-06-26 MX MX9203599A patent/MX9203599A/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP0299379A1 (de) | 1989-01-18 |
AU626526B2 (en) | 1992-08-06 |
HU205902B (en) | 1992-07-28 |
PT87953B (pt) | 1995-03-01 |
NO883084L (no) | 1989-01-11 |
HUT48594A (en) | 1989-06-28 |
PH24605A (en) | 1990-08-17 |
CZ394991A3 (en) | 1993-01-13 |
PT87953A (pt) | 1989-06-30 |
JPS6431766A (en) | 1989-02-02 |
US4788206A (en) | 1988-11-29 |
ES2054740T3 (es) | 1994-08-16 |
YU132488A (en) | 1991-02-28 |
ATE88466T1 (de) | 1993-05-15 |
FI883290A (fi) | 1989-01-11 |
DK378188A (da) | 1989-01-11 |
YU46716B (sh) | 1994-04-05 |
NO883084D0 (no) | 1988-07-08 |
DE3880387D1 (de) | 1993-05-27 |
MX9203599A (es) | 1992-07-01 |
MC1954A1 (fr) | 1989-06-30 |
FI883290A0 (fi) | 1988-07-08 |
ZA884857B (en) | 1989-04-26 |
IL87017A0 (en) | 1988-12-30 |
AU1885188A (en) | 1989-01-12 |
DK378188D0 (da) | 1988-07-07 |
NZ225327A (en) | 1991-08-27 |
EP0299379B1 (de) | 1993-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR890001989A (ko) | 펜타디엔아미드 | |
DE69208496D1 (de) | Bernsteinsäurederivate | |
KR890001988A (ko) | 치환된 알켄카복실산아미드 및 이의유도체 | |
KR890014537A (ko) | 5-치환 [4,5-c]이미다조피리딘류 | |
NO159269C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske fenylamidiner. | |
JP2020531496A5 (ko) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |